Vaccination News Home Page

http://www.nature.com/nsu/021216/021216-1.html

nature science update
updated at midnight GMT today is sunday, december 22
features
nature science update home
content
news
features
by subject
conferences
services
send to a friend
printable version
ealert
search
help
feedback
information
about the site
about us
amersham logo
American Society for Cell Biology,
San Francisco, December, 2002

 

Deviant gatherings prompt brain disease

Trapped proteins may explain nerve degeneration.
16 December 2002

HELEN PEARSON

 

Drug companies are looking for molecules that alter protein shuttling.
© GettyImages

 

Many degenerative brain disorders could arise because culprit proteins are unable to escape the cell's nucleus, gathering data suggest. Messed up cell transport is increasingly suspected as a cause of disease.

Proteins encoded by an abnormal string of stutter-like DNA repeats are involved in a group of neurological conditions including Huntington's disease. Scientists have scratched their heads over how the anomaly causes the nerve-cell deterioration that strikes in middle age.

The proteins have lost the ability to escape the nucleus and ferry molecules elsewhere in the nerve cells, suggest Ray Truant of McMaster University in Ontario, Canada, and his colleagues. "The parallels between the diseases are starting to come together," he said at this week's American Society for Cell Biology meeting in San Francisco.

If the theory proves true, the stray proteins might be redirected, hopes Harry Orr, who studies 'triplet repeat' diseases at the University of Minnesota in Minneapolis. Some drug companies are already using high-throughput screens to hunt for molecules that alter protein shuttling.

Certain control proteins in the cell ensure that others are shunted correctly. "These pathways might become amenable to small-molecule drug therapies," suggests Orr.

No way out

Huntington's, an inherited disease that causes cognitive and movement difficulties, affects 1 in 10,000 people; spinocerebellar ataxia type-1 is a coordination and speech disorder in the same disease family.

Biologists knew that mutant forms of the culprit proteins huntingtin and ataxin-1 accumulate in affected nerve cells. Truant and his team found that disease-causing versions of ataxin-1 cannot carry essential RNA molecules out of the nucleus.

 

Abnormal trafficking could have dramatic repercussions for different types of cell
Harry Orr
University of Minnesota

 

Diseased ataxin-1 moves up to ten times slower than normal, they saw, by filming living cells. Orr, meanwhile, showed that one type of RNA accumulates when ataxin-1 is defective. Huntingtin too, has a section that shuttles other proteins out of the nucleus, claims Truant.

Other laboratories have recently found that proteins implicated in Fragile X syndrome and X-linked mental retardation cannot exit the nucleus or process RNA.

Abnormal trafficking might starve the cell of the correct RNAs to make proteins. "It could have dramatic repercussions for different types of cell," says Orr.


© Nature News Service / Macmillan Magazines Ltd 2002
related stories
New model for neurodegenerative disease
2 November 2000
Challenges and opportunities
13 April 2000
Hunting down Huntington's disease
20 May 1999
links out
American Society for Cell Biology
Huntington's Disease Association
Huntington's Disease Information
more news
Green snow washes clean away
23 December 2002
Electric dreams infect waking memories
23 December 2002
Black Crunch jams Universal cycle
23 Decemeber 2002
Chemical attraction solves geometric puzzles
23 December 2002
Foot-and-Mouth would have jumped fence
23 December 2002
Ultrasound scan spots Down's syndrome
20 December 2002
Humans more similar than different
20 December 2002
science books
Amazon.com
cover
Beyond Codependency
Melody Beattie
New $4.35!
Used $3.00!
(Prices May Change)
Privacy Information

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.